Novartis India Shares Surge 4.58% on Financial Update

Novartis India Ltd. shares advanced by 4.58% on August 31, 2026, closing at ₹1,554.40. This upward movement represented a gain of ₹68.10 for the diversified pharmaceutical company.

Snapshot of Key Financials

• Market Capitalization: ₹3,843 Cr
• Trailing Twelve Months (TTM) Revenue: ₹371 Cr
• Price/Earnings (P/E) Ratio: 39.3
• Price/Book (P/B) Ratio: 4.5
• Dividend Yield: 0%

The company, identified by NSE code NOVARTIND and BSE code 500672, operates within the Healthcare and Pharmaceuticals – Diversified sectors, reflecting its broad market engagement.

Detailed Financials Under Premium Lock

Value Research Online provides a financial overview of Novartis India Ltd., encompassing snapshot data for its balance sheet, profit & loss, and cash flow statements. However, access to comprehensive historical financial statements and detailed ratios is restricted.

While summary metrics are public, specific historical data for key performance indicators such as Adjusted EPS, Return on Capital Employed (ROCE), Return on Equity (ROE), and Revenue Growth are marked as premium content. Other ratio categories like Price/Earnings, Debt to Equity, Current Ratio, and Debtors to sales also require a subscription for full access.

Despite these restrictions, certain asset figures remain visible. These include Non-Current Assets, Current Assets, and Total Assets for recent fiscal years, alongside reported Total Debt, Net Current Assets, and Contingent Liabilities within the company’s financial disclosures.